Scleroderma-Associated Pulmonary Hypertension: Who's at Risk and Why

Advances in Pulmonary Hypertension
doi 10.21693/1933-088x-1.2.5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pulmonary Hypertension Association

Related search

Scleroderma Associated Pulmonary Hypertension

Advances in Pulmonary Hypertension
2008English

Pulmonary Arterial Hypertension Associated With Scleroderma

Advances in Pulmonary Hypertension
2008English

Soluble Thrombomodulin Concentration Is Raised in Scleroderma Associated Pulmonary Hypertension

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2000English

Ambrisentan and Tadalafil Up-Front Combination Therapy in Scleroderma-Associated Pulmonary Arterial Hypertension

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2015English

Borderline Pulmonary Pressures in Scleroderma - A ‘Pre-Pulmonary Arterial Hypertension’ Condition?

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2015English

Sleep Apnea and Epilepsy: Who's at Risk?

Epilepsy and Behavior
NeurologyBehavioral Neuroscience
2012English

Risk Assessment in Scleroderma Patients With Newly Diagnosed Pulmonary Arterial Hypertension: Application of the ESC/ERS Risk Prediction Model

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2018English

Haemodynamics and Serial Risk Assessment in Systemic-Sclerosis Associated Pulmonary Arterial Hypertension

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2018English

Telangiectases in Scleroderma: A Potential Clinical Marker of Pulmonary Arterial Hypertension

Journal of Rheumatology
RheumatologyAllergyImmunology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy